Benedic Ippolito

3 weeks ago | aei.org | Scott Gottlieb |James Pethokoukis |David Shaywitz |Benedic Ippolito

Press CNBC Discussing the impact of President Trump’s policies on life science investment and innovation: Gottlieb on CNBC’s ‘Squawk Box’ Article How to Stop the Shift of Drug Discovery from the US to China Press Discussing the new Trump Administration and US health policy: Gottlieb on CNBC’s ‘Special Report’ Press CNBC Discussing the GLP-1 Drug Trade and Developments: Gottlieb on CNBC’s “Fast Money” Article Will the Anti-Obesity Wonder Drugs Work Wonders for the US Economy? Press CNBC...

2 months ago | aei.org | Frederick M. Hess |Robert Doar |Benedic Ippolito |Amitabh Chandra

The first 100 days of President Donald Trump’s second term have featured a torrent of education activity. President Trump moved to abolish the US Department of Education, slashing its workforce and yanking hundreds of millions of dollars in grants. He issued executive orders expanding school choice and demanding changes in how institutions manage gender, antisemitism, and diversity, equity, and inclusion.

2 months ago | aei.org | Frederick M. Hess |Naomi Schaefer Riley |Robert Doar |Benedic Ippolito

In the early months of the second Trump administration, conservative frustration with universities has fueled a furious burst of activity. President Donald Trump has slashed the US Department of Education and federal education research, sought to squeeze overhead rates on National Institutes of Health grants, and issued executive orders on gender, antisemitism, and diversity, equity, and inclusion on college campuses.

Feb 6, 2025 | aei.org | Amitabh Chandra |Benedic Ippolito |Daniel Cox |Brad Wilcox

Federal policy can significantly alter drugmakers’ incentives, yet there is substantial debate about how various proposals will affect the development of new drugs. At this event, experts will present the latest research on how drug development responds to policy changes—including those introduced by the Inflation Reduction Act—and what that means for coming policy debates.

Jan 7, 2025 | aei.org | Benedic Ippolito |Julia Cataneo

The Biden Administration has issued a new rule that bans all medical bills from consumer credit reports, marking the culmination of years of policy efforts. While the rule stands to benefit some consumers, policymakers should be attentive to responses by lenders and health care providers that could undercut policy goals. The new rule, announced by the Consumer Financial Protection Bureau, is motivated by the concern that medical bills may not always reflect creditworthiness.